Gerend Mary A, Barley Jessica
Department of Medical Humanities and Social Sciences, Florida State University College of Medicine, Tallahassee, Florida, USA.
Sex Transm Dis. 2009 Jan;36(1):58-62. doi: 10.1097/OLQ.0b013e31818606fc.
For human papillomavirus (HPV) vaccination to have maximum benefit to public health, both men and women should be vaccinated. Although efficacy trials in men are still ongoing, the HPV vaccine will likely be licensed for men in the near future. Little is known about men's interest in HPV vaccination. This study assessed whether informing men about the benefits of male HPV vaccination for their female sexual partner(s) boosted interest in the HPV vaccine beyond informing them about the benefits to men alone. Predictors of HPV vaccine acceptability were also identified.
Heterosexual male college students (n = 356) were randomly assigned to receive a self-protection versus a self-protection and partner protection message about HPV and the quadrivalent HPV vaccine. Participants provided demographic and sexual history information, HPV-related awareness and knowledge, health beliefs, and HPV vaccination intentions.
: Men reported moderate interest in the HPV vaccine; vaccine acceptability did not differ by experimental condition. A multivariate regression model identified several independent predictors of HPV vaccine acceptability including sexual activity, perceived susceptibility to HPV, perceived benefits of the vaccine, perceived hassle and cost of vaccination, self-efficacy for vaccination, and perceived norms for vaccination.
Informing men about the benefits of male HPV vaccination for reducing cervical cancer risk in women did not increase men's interest in the vaccine. Correlates of vaccine acceptability among men were generally consistent with those identified for women. Findings have important implications for future HPV vaccination campaigns targeting young adult men.
为使人类乳头瘤病毒（HPV）疫苗接种对公共卫生产生最大益处，男性和女性都应接种。尽管针对男性的疗效试验仍在进行中，但HPV疫苗可能在不久的将来获得针对男性的许可。人们对男性接种HPV疫苗的兴趣知之甚少。本研究评估了向男性告知接种HPV疫苗对其女性性伴侣的益处，是否会比仅告知对男性自身的益处更能提高他们对HPV疫苗的兴趣。还确定了HPV疫苗可接受性的预测因素。
将异性恋男大学生（n = 356）随机分配，使其接收关于HPV和四价HPV疫苗的自我保护信息或自我保护及伴侣保护信息。参与者提供了人口统计学和性史信息、HPV相关的意识和知识、健康观念以及HPV疫苗接种意愿。
男性报告对HPV疫苗有中等兴趣；疫苗可接受性在不同实验条件下无差异。一个多元回归模型确定了几个HPV疫苗可接受性的独立预测因素，包括性活动、对HPV的感知易感性、对疫苗的感知益处、对疫苗接种麻烦程度和成本的感知、疫苗接种的自我效能感以及对疫苗接种的感知规范。
向男性告知接种HPV疫苗对降低女性宫颈癌风险的益处，并未增加男性对该疫苗的兴趣。男性中疫苗可接受性的相关因素总体上与女性中确定的因素一致。研究结果对未来针对年轻成年男性的HPV疫苗接种运动具有重要意义。
